The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 26005023 |
25 |
(±) cis-Bisamido epoxides: A novel series of potent FXIII-A inhibitors. |
University Of Leeds |
| 25415134 |
5 |
Novel insights into structure and function of factor XIIIa-inhibitor tridegin. |
University Of Bonn |
| 24432384 |
7 |
Tissue transglutaminase: an emerging target for therapy and imaging. |
TBA |
| 23835447 |
32 |
Imidazolium-based warheads strongly influence activity of water-soluble peptidic transglutaminase inhibitors. |
Aston University |
| 22224594 |
346 |
Discovery and structure-activity relationship of potent and selective covalent inhibitors of transglutaminase 2 for Huntington's disease. |
Evotec (Uk) |
| 24900424 |
60 |
SAR Development of Lysine-Based Irreversible Inhibitors of Transglutaminase 2 for Huntington's Disease. |
TBA |
| 24900540 |
47 |
Irreversible 4-Aminopiperidine Transglutaminase 2 Inhibitors for Huntington's Disease. |
TBA |
| 15801818 |
18 |
3-Substituted imidazo[1,2-d][1,2,4]-thiadiazoles: a novel class of factor XIIIa inhibitors. |
Apotex Research |
Search and Browse
